VestGen Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.9M Buy
+27,550
New +$2.56M 0.09% 210

Other funds holding HAE

VestGen Advisors's HAE Position: Q3 2026 in Review

VestGen Advisors opened a new position in Haemonetics (HAE) in Q3 2026: 27,550 shares worth $2.9M. The stake represents 0.09% of the portfolio and ranks #210 among its holdings.

361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • VestGen Advisors held 27,550 shares of Haemonetics worth $2.9M as of Q3 2026.
  • Haemonetics was a new VestGen Advisors position in Q3 2026.
  • Haemonetics made up 0.09% of VestGen Advisors's portfolio in Q3 2026, its #210 holding.
  • 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.